2022
DOI: 10.3389/fneur.2022.1043785
|View full text |Cite
|
Sign up to set email alerts
|

Ovarian resection in anti-N-methyl-D-aspartate receptor encephalitis: A comparison of surgical approaches

Abstract: BackgroundFor patients with anti-N-methyl-D-aspartate receptor encephalitis (NMDARE) and ovarian teratoma, “conservative” surgical approaches (complete or partial unilateral oophorectomy or bilateral partial oophorectomies) are associated with clinical improvement. “Aggressive” ovarian resections (complete bilateral oophorectomy or “blind” ovarian resections without pre-operative evidence of teratoma) are also reported, although the evidence supporting these approaches is unclear.ObjectiveTo compare the one-ye… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…In cases of severe refractory NMDAR antibody encephalitis, evidence for bilateral "blind" oophorectomy for removal of potential occult ovarian teratoma is limited. 144 The existing evidence is predominantly based on case series/case reports, many of which were published before options for third-line treatment were available. Given the permanent effects on fertility/iatrogenic menopause and the fact that most patients with refractory NMDAR antibody encephalitis would be unable to provide informed consent due to their underlying disease, such procedures should only be undertaken as a last resort and with informed consent through a surrogate decision maker.…”
Section: Special Considerations For Refractory Nmdar-igg Aiementioning
confidence: 99%
“…In cases of severe refractory NMDAR antibody encephalitis, evidence for bilateral "blind" oophorectomy for removal of potential occult ovarian teratoma is limited. 144 The existing evidence is predominantly based on case series/case reports, many of which were published before options for third-line treatment were available. Given the permanent effects on fertility/iatrogenic menopause and the fact that most patients with refractory NMDAR antibody encephalitis would be unable to provide informed consent due to their underlying disease, such procedures should only be undertaken as a last resort and with informed consent through a surrogate decision maker.…”
Section: Special Considerations For Refractory Nmdar-igg Aiementioning
confidence: 99%